Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism

Journal of Sexual Medicine

Volumn 11, Issue 5, 2014, Pages 1302-1308

  Tirabassi, Giacomo ^a   delli Muti, Nicola ^a   Corona, Giovanni ^b,c   Maggi, Mario ^c   Balercia, Giancarlo ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b BELLARIA HOSPITAL   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Androgen receptor; Hypogonadotropic hypogonadism; International index of erectile function questionnaire; Sexual function; Testosterone replacement therapy

Indexed keywords

ANDROGEN RECEPTOR; HYDROCORTISONE; HYPOPHYSIS HORMONE; LIOTHYRONINE; PROLACTIN; SOMATOMEDIN C; TESTOSTERONE; THYROXINE;

ADULT; ANDROGEN THERAPY; ARTICLE; CAG REPEAT; CANCER SURGERY; CLINICAL ARTICLE; CONVALESCENCE; DNA POLYMORPHISM; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GENE NUMBER; GENETIC ANALYSIS; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS ADENOMA; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LIOTHYRONINE BLOOD LEVEL; MALE; MALE SEXUAL DYSFUNCTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEXUAL FUNCTION; TESTOSTERONE BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ANDROGEN RECEPTOR; HYPOGONADOTROPIC HYPOGONADISM; INTERNATIONAL INDEX OF ERECTILE FUNCTION QUESTIONNAIRE; SEXUAL FUNCTION; TESTOSTERONE REPLACEMENT THERAPY;

ANDROGENS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTOPERATIVE COMPLICATIONS; RECEPTORS, ANDROGEN; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE; TRINUCLEOTIDE REPEATS;

EID: 84899485863     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12493     Document Type: Article

References (28)

1. McPhaul MJ. Molecular defects of the androgen receptor. Recent Prog Horm Res 2002;57:181-194.
2. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994;22:3181-3186.
3. Lewis RW, Mills TM. Effect of androgens on penile tissue. Endocrine 2004;23:101-105.
4. Bancroft J. The endocrinology of sexual arousal. J Endocrinol 2005;186:411-427.
5. Pastuszak A, Badhiwala N, Lipshultz L, Khera M. Androgen receptor CAG repeat length correlates with sexual function and hypogonadal symptoms in men. Presented at the World Meeting on Sexual Medicine, Chicago, IL, USA, August 26-30, 2012.
6. Andersen ML, Guindalini C, Santos-Silva R, Bittencourt LR, Tufik S. Androgen receptor CAG repeat polymorphism is not associated with erectile dysfunction complaints, gonadal steroids, and sleep parameters: Data from a population-based survey. J Androl 2011;32:524-529.
7. Granata A, Tirabassi G, Pugni V, Arnaldi G, Boscaro M, Carani C, Balercia G. Sexual dysfunctions in men affected by autoimmune Addison's disease before and after short-term gluco- and mineralocorticoid replacement therapy. J Sex Med 2013;10:2036-2043.
8. Maggi M, Buvat J, Corona G, Guay A, Torres LO. Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA). J Sex Med 2013;10:661-677.
9. Tirabassi G, Gioia A, Giovannini L, Boscaro M, Corona G, Carpi A, Maggi M, Balercia G. Testosterone and cardiovascular risk. Intern Emerg Med 2013;8(1 suppl):65-69.
10. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM; Endocrine Society Task Force. Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95:2536-2559.
11. Gabellieri E, Chiovato L, Lage M, Castro AI, Casanueva FF. Testing growth hormone deficiency in adults. Front Horm Res 2010;38:139-144.
12. Persani L. Clinical review: Central hypothyroidism: Pathogenic, diagnostic, and therapeutic challenges. J Clin Endocrinol Metab 2012;97:3068-3078.
13. Grossman AB. Clinical review: The diagnosis and management of central hypoadrenalism. J Clin Endocrinol Metab 2010;95:4855-4863.
14. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010;33(1 suppl):S11-61.
15. Lim LS, Haq N, Mahmood S, Hoeksema L; ACPM Prevention Practice Committee; American College of Preventive Medicine. Atherosclerotic cardiovascular disease screening in adults: American College of Preventive Medicine position statement on preventive practice. Am J Prev Med 2011;40:381, e1-10.
16. Saad F, Kamischke A, Yassin A, Zitzmann M, Schubert M, Jockenhel F, Behre HM, Gooren L, Nieschlag E. More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate. Asian J Androl 2007;9:291-297.
17. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-830.
18. delli Muti N, Agarwal A, Buldreghini E, Gioia A, Lenzi A, Boscaro M, Balercia G. Have androgen receptor gene CAG and GGC repeat polymorphisms an effect on sperm motility in infertile men? Andrologia 2013. doi: 10.1111/and.12119. [Epub ahead of print].
19. Bouvattier C, Mignot B, Lefèvre H, Morel Y, Bougnères P. Impaired sexual activity in male adults with partial androgen insensitivity. J Clin Endocrinol Metab 2006;91:3310-3315.
20. Galdiero M, Pivonello R, Grasso LF, Cozzolino A, Colao A. Growth hormone, prolactin, and sexuality. J Endocrinol Invest 2012;35:782-794.
21. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010;31:702-755.
22. Penson DF, Ng C, Rajfer J, Gonzalez-Cadavid NF. Adrenal control of erectile function and nitric oxide synthase in the rat penis. Endocrinology 1997;138:3925-3932.
23. Arnaldi G, Mancini T, Tirabassi G, Trementino L, Boscaro M. Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications. J Endocrinol Invest 2012;35:434-448.
24. Tirabassi G, Papa R, Faloia E, Boscaro M, Arnaldi G. Corticotrophin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and pseudo-Cushing state: A comparative study. Clin Endocrinol (Oxf) 2011;75:666-672.
25. Tirabassi G, Faloia E, Papa R, Furlani G, Boscaro M, Arnaldi G. Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease. J Clin Endocrinol Metab 2010;95:1115-1122.
26. Arnaldi G, Tirabassi G, Papa R, Furlani G, Trementino L, Cardinaletti M, Faloia E, Boscaro M. Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. Eur J Endocrinol 2009;160:891-898.
27. Isidori AM, Giannetta E, Gianfrilli D, Greco EA, Bonifacio V, Aversa A, Isidori A, Fabbri A, Lenzi A. Effects of testosterone on sexual function in men: Results of a meta-analysis. Clin Endocrinol (Oxf) 2005;63:381-394.
28. Chiang HS, Cho SL, Lin YC, Hwang TI. Testosterone gel monotherapy improves sexual function of hypogonadal men mainly through restoring erection: Evaluation by IIEF score. Urology 2009;73:762-766.